Skip to main content
. 2020 Sep 3;246(1):20–30. doi: 10.1177/1535370220955139

Figure 2.

Figure 2.

SNHG1 silencing enhanced baicalein-caused cell viability repression, apoptosis induction, and migration repression in cervical cancer cells. (a) SNHG1 expression in HeLa cells silencing SNHG1 or control was assessed using qRT-PCR and northern blot. (b) HeLa cells silencing SNHG1 or control were treated with different doses of baicalein (0, 25, 50, 100 µM) for 24 h, followed by Glo cell viability assay to detect cell viability. (c) HeLa cells silencing SNHG1 or control were treated with 100 µM baicalein for 24 h, followed by EdU incorporation assay to detect cell viability. (d) HeLa cells silencing SNHG1 or control were treated with 100 µM baicalein for 24 h, followed by TUNEL assay to detect cell apoptosis. (e) Cell migration of HeLa cells silencing SNHG1 or control and simultaneous treatment with 50 µM baicalein for 48 h was detected by transwell migration assay. Results are shown as mean ± SD. Scale bars, 100 µm. **P < 0.01, ***P < 0.001. (A color version of this figure is available in the online journal.)